Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020;17(1):20-40.
doi: 10.1080/15427609.2020.1743810. Epub 2020 Jul 1.

Glycosylated hemoglobin level, race/ethnicity, and cognition in midlife and early old age

Affiliations

Glycosylated hemoglobin level, race/ethnicity, and cognition in midlife and early old age

Kasim Ortiz et al. Res Hum Dev. 2020.

Abstract

Empirical evidence linking racial/ethnic differences in glycosylated hemoglobin levels (HbA1c) to cognitive function in midlife and early old age is limited. We use biomarker data from the Health and Retirement Study (HRS, 2006-2014), on adults 50-64 years at baseline (57-73 years by 2014), and fit multinomial logistic regression models to assess the association between baseline HbA1c, cognitive function (using Langa-Weir classifications) and mortality across 8-years. Additionally, we test for modification effects by race/ethnicity. In age- and sex-adjusted models high HbA1c level was associated with lower baseline cognition and higher relative risk ratios (RRR; vs. normal cognition) for cognitive impairment no dementia (CIND; RRR= 2.3; 95%CI=[1.38;3.84]; p<0.01), and dementia (RRR= 4.00; 95%CI=[1.76;9.10]; p<0.01). Adjusting for sociodemographic, behavioral risk factors, and other health conditions explained the higher RRR for CIND and attenuated the RRR for dementia by approximately 30%. HbA1c levels were not linked to the slope of cognitive decline, and we found no evidence of modification effects for HbA1c by race/ethnicity. Targeting interventions for glycemic control in the critical midlife period can protect baseline cognition and buffer against downstream development of cognitive impairment. This can yield important public health benefits and reductions in burdens associated with cognitive impairment, particularly among race/ethnic minorities who are at higher risk for metabolic diseases.

Keywords: cognitive functioning; glycemic levels; race/ethnicity.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Estimated average marginal probabilities of longitudinal (2014) Langa-Weir cognitive status classification (Normal, CIND, and Dementia) by baseline HbA1c level CIND=Cognitive impairment not dementia Full adjustment indicates additional adjustment for race/ethnicity, marital status, insurance status, census region, alcohol consumption, smoking status, BMI (kg/m2), and count of chronic conditions

Similar articles

Cited by

References

    1. Arnold SE, Arvanitakis Z, Macauley-Rambach SL, Koenig AM, Wang H-Y, Ahima RS, … Nathan DM (2018). Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums. Nature Reviews Neurology, 14(3), 168–181. doi:10.1038/nrneurol.2017.185 - DOI - PMC - PubMed
    1. Arvanitakis Z, Capuano AW, Bennett DA, & Barnes LL (2017). Body mass index and decline in cognitive function in older black and white persons. The Journals of Gerontology: Series A, 73(2), 198–203. - PMC - PubMed
    1. Avila JF, Vonk JM, Verney SP, Witkiewitz K, Rentería MA, Schupf N, … Manly JJ (2019). Sex/gender differences in cognitive trajectories vary as a function of race/ethnicity. Alzheimer’s & Dementia. - PMC - PubMed
    1. Babulal GM, Quiroz YT, Albensi BC, Arenaza-Urquijo E, Astell AJ, Babiloni C, … Brickman AM (2019). Perspectives on ethnic and racial disparities in Alzheimer’s disease and related dementias: Update and areas of immediate need. Alzheimer’s & Dementia, 15(2), 292–312. - PMC - PubMed
    1. Banks J, Muriel A, & Smith JP (2011). Attrition and health in ageing studies: Evidence from ELSA and HRS. Longitudinal and life course studies, 2(2), 10.14301/llcs.v14302i14302.14115. doi:10.14301/llcs.v2i2.115 - DOI - DOI - PMC - PubMed

LinkOut - more resources